The Technical Analyst
iSpecimen Inc. [ISPC]
Exchange: NASDAQ Sector: Healthcare Industry: Diagnostics & Research
iSpecimen Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals
-13.21% $0.295
America/New_York / 23 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 2.68 mill |
| EPS: | -1.230 |
| P/E: | -0.240 |
| Earnings Date: | May 02, 2024 |
| SharesOutstanding: | 9.09 mill |
| Avg Daily Volume: | 0.841 mill |
| RATING 2024-04-23 |
|---|
| B- |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Sell | |
| DE: | Neutral | |
| P/E: | Neutral | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.240 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.01x |
| Company: PE -0.240 | industry: PE 18.71 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.257 - 0.333 ( +/- 12.88%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-03-21 | Graham Elizabeth Ames | Buy | 0 | |
| 2023-12-31 | Mock Theresa L | Buy | 0 | |
| 2023-09-14 | Bielak Benjamin | Buy | 18 000 | Common Stock |
| 2023-05-31 | Curley Tracy | Buy | 4 400 | Common Stock |
| 2023-01-01 | Basile Joseph J. | Buy | 63 | Common Stock |
| INSIDER POWER |
|---|
| 46.30 |
| Last 89 transactions |
| Buy: 2 325 819 | Sell: 3 264 500 |
Forecast:
16:00 - $0.295
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $0.295
Forecast 2: 16:00 - $0.295
Forecast 3: 16:00 - $0.295
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $0.295 (-13.21% ) |
| Volume | 0.470 mill |
| Avg. Vol. | 0.841 mill |
| % of Avg. Vol | 55.96 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For ISPC
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
ISPC
iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.
Latest Press Releases
2024-03-14 08:00:00 - Press Release
Ispecimen Reports Full Year 2023 Results
Lexington, mass., march 14, 2024 (globe newswire) -- ispecimen inc. (nasdaq: ispc) (“ispecimen” or the “company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today reported its financial and operating results for the twelve-month period ended december 31, 2023.
2024-03-12 19:07:00 - Press Release
Ispecimen Reschedules Full Year 2023 Earnings Release And Conference Call
The company will now report results after the market closes on march 13, 2024 and reschedules conference call to thursday, march 14, 2024 at 8:30am eastern the company will now report results after the market closes on march 13, 2024 and reschedules conference call to thursday, march 14, 2024 at 8:30am eastern
2024-03-05 16:30:00 - Press Release
Ispecimen To Report Full Year 2023 Financial Results On March 13, 2024
Lexington, mass., march 05, 2024 (globe newswire) -- ispecimen inc. (nasdaq: ispc) (“ispecimen” or the “company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that it will report its financial results for the full year ended december 31, 2023 before the market opens on wednesday, march 13, 2024.
2024-01-23 07:30:00 - Press Release
Ispecimen And Trimetis Life Sciences Announce Strategic Partnership To Help Transform Tissue-based Research
Partnership aims to optimize quality control and assurance through digital ai histopathology services partnership aims to optimize quality control and assurance through digital ai histopathology services
2024-01-18 08:11:00 - Press Release
Ispecimen To Participate In Maxim Group Healthcare It Virtual Conference, January 24 & 25, 2024
Lexington, mass., jan. 18, 2024 (globe newswire) -- ispecimen inc. (nasdaq: ispc) (“ispecimen” or the “company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today that it will be participating in the maxim group virtual healthcare it conference on january 25, 2024. tracy curley, chief executive officer, will present at 10:00 a.m. et.
Latest News
2024-03-12 19:07:00 - GlobeNewsWire
iSpecimen Reschedules Full Year 2023 Earnings Release and Conference Call
The Company will now report results after the market closes on March 13, 2024 and reschedules conference call to Thursday, March 14, 2024 at 8:30am Eastern The Company will now report results after the market closes on March 13, 2024 and reschedules conference call to Thursday, March 14, 2024 at 8:30am Eastern
2024-03-05 16:30:00 - GlobeNewsWire
iSpecimen to Report Full Year 2023 Financial Results on March 13, 2024
LEXINGTON, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that it will report its financial results for the full year ended December 31, 2023 before the market opens on Wednesday, March 13, 2024.
2023-11-03 16:39:04 - Seeking Alpha
iSpecimen Inc. (ISPC) Q3 2023 Earnings Call Transcript
iSpecimen Inc. (NASDAQ:ISPC ) Q3 2023 Earnings Conference Call November 2, 2023 8:30 AM ET Company Participants Phil Carlson - Investor Relations, KCSA Strategic Communications Tracy Curley - Chief Executive Officer and Chief Financial Officer Benjamin Bielak - Chief Information Officer Eric Langlois - Chief Revenue Officer Carly Lejnieks - Vice President of Marketing. Conference Call Participants Matt Hewitt - Craig Hallum Operator Good day, everyone, and welcome to iSpecimens Third Quarter 2020 Results Conference Call.
2023-08-05 10:22:09 - Seeking Alpha
iSpecimen Inc. (ISPC) Q2 2023 Earnings Call Transcript
iSpecimen Inc. (NASDAQ:ISPC ) Q2 2023 Earnings Conference Call August 2, 2023 8:30 AM ET Company Participants Phil Carlson - Investor Relations, KCSA Strategic Communications Tracy Curley - Chief Executive Officer and Chief Financial Officer Eric Langlois - Chief Revenue Officer Evan Cox - Vice President of Product Management Conference Call Participants Operator Good day, everyone, and welcome to iSpecimen's Second Quarter 2023 Results Conference Call. At this time participants are in a listen-only mode.
2023-07-25 07:30:00 - GlobeNewsWire
iSpecimen to Report Second Quarter 2023 Results on August 2, 2023
LEXINGTON, Mass., July 25, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that it will report its financial results for the second quarter ended June 30, 2023 before the market opens on Wednesday, August 2, 2023.
2023-05-23 07:30:00 - GlobeNewsWire
iSpecimen to Participate in Maxim's Healthcare IT Virtual Conference on June 1, 2023
LEXINGTON, Mass., May 23, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that Tracy Curley, CEO of iSpecimen, will participate in the Healthcare IT Virtual Conference hosted by Maxim Group LLC (“Maxim”) and M-Vest, a division of Maxim, on Thursday, June 1, 2023.
2023-05-06 18:25:20 - Seeking Alpha
iSpecimen Inc. (ISPC) Q1 2023 Earnings Call Transcript
iSpecimen Inc. (NASDAQ:ISPC ) Q1 2023 Results Conference Call May 4, 2023 8:30 AM ET Company Participants Tracy Curley - Chief Executive Officer Benjamin Beilak - Chief Information Officer Eric Langlois - Chief Revenue Officer Conference Call Participants Matt Hewitt - Craig Hallum Capital Group Operator Good morning, and welcome to iSpecimen First Quarter 2023 Earnings Conference Call [Operator Instructions]. Please note that this event is being recorded.
2023-04-24 07:30:00 - GlobeNewsWire
iSpecimen to Participate in the Aegis Virtual Conference on May 4, 2023
LEXINGTON, Mass., April 24, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that Tracy Curley, CEO of iSpecimen, will participate in the Aegis Conference to be held virtually on May 2-4, 2023.
2023-03-14 14:18:08 - Seeking Alpha
iSpecimen Inc. (ISPC) Q4 2022 Earnings Call Transcript
iSpecimen Inc. (NASDAQ:ISPC ) Q4 2022 Earnings Call Transcript March 14, 2023 8:30 AM ET Company Participants Allison Soss - Investor Relations-KCSA Strategic Communications Tracy Curley - Chief Executive Officer Benjamin Bielak - Chief Information Officer Eric Langlois - Chief Revenue Officer Conference Call Participants Matt Hewitt - Craig-Hallum Capital Group Allen Klee - Maxim Group Operator Good day, everyone and welcome to iSpecimen's Full Year 2022 Conference Call. At this time, participants will be in a listen-only mode.
2023-03-14 09:38:53 - Proactive Investors
iSpecimen sees 4Q revenue rise by 28% as it focuses on its supplier network and fulfillment efficiency
iSpecimen Inc said its revenue jumped 28% year-over-year in the fourth quarter as it made quick improvements to supplier utilization rates to boost overall fulfillment efficiency. For the period ended December 31, 2022, the Lexington, Massachusetts-based company reported revenue of $3.2 million, compared to $2.5 million in 4Q 2021.